EPCAM and neoplasm: While sorted cell populations ranged from 0.04% to 0.27% as expected in the four primary tumor regions, we detected a smaller proportion of EPCAM+CD44+CD49f+ cells in the lymph nodes ranging from 0.002% to 0.004% (Supplementary Figure 1B).